Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Barcelona
Clinical trial register · Spain

Clinical Trials in Barcelona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Madrid 109 Barcelona 96 Pamplona 44 Seville 40 Badalona 33
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca188 Merck Sharp & Dohme LLC113 Novartis Pharmaceuticals111 Janssen Research & Development, LLC96 Hoffmann-La Roche85 Clear sponsor filter
Site location
Madrid109 Barcelona96 Pamplona44 Seville40 Badalona33
All 68 locations
Target enrolment
to

Trials with a site in Barcelona

96 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Barcelona, Cáceres, Córdoba, Jerez de la Frontera, Madrid, Pamplona, Salamanca, Santander
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Alicante, Barcelona, Ferrol, Gijón, Girona, Madrid, Navarra, Santiago de Compostela
2026-04-21
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Barcelona, Huelva, Madrid, Pamplona, Santander, Santiago de Compostela, Seville, Valladolid
2026-03-05
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Badalona, Barcelona, Granada, Madrid, Pozuelo de Alarcón, Salamanca, Usansolo, Valencia
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 1
340
Barcelona, Madrid
2026-01-20
Recruiting
Janssen Research & Development, LLC
Phase 3
258
Barcelona, Esplugues de Llobregat, Madrid, Manresa, Oviedo, Pamplona, Sabadell
2026-01-08
Recruiting
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
NCT07194070Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC
Observational
175
Barcelona
2025-12-17
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santiago de Compostela, Valencia, Zaragoza
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Barcelona, Gijón, Girona, Madrid, Santiago de Compostela, Seville, Valencia
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 2
60
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Santander, Seville
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Barcelona, Ferrol, Galdakao, Gijón, Girona, Madrid, Santiago de Compostela, Seville
2025-10-01
Recruiting
Janssen Research & Development, LLC
Phase 3
220
A Coruña, Barcelona, Cadiz, Castellon, Ferrol, Jerez de la Frontera, Madrid, Málaga
2025-09-10
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Barcelona, Jerez de la Frontera, Madrid, Málaga
2025-09-02
Recruiting
Janssen Research & Development, LLC
Phase 1
400
Barcelona, Madrid
2025-07-15
Recruiting
Janssen Research & Development, LLC
Phase 3
600
A Coruña, Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón
2025-06-04
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Alicante, Barakaldo, Barcelona, Granada, Madrid, Manises, Santiago Compostela, Seville
2025-04-15
Active, closed
Janssen Research & Development, LLC
Phase 3
552
A Coruña, Barcelona, Córdoba, Madrid, Málaga, Sabadell, Santander, Seville
2025-02-21
Active, closed
Janssen Research & Development, LLC
Phase 1
64
Barcelona, Madrid, Pamplona
2025-01-14
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
Barcelona, Madrid, Pamplona, Salamanca
2024-12-30
Active, closed
Janssen Research & Development, LLC
Phase 1
17
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2024-12-19
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Barcelona, Jerez de la Frontera, Madrid, Santiago de Compostela, Valencia
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Badajoz, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2024-12-12
Recruiting
Janssen Research & Development, LLC
Phase 1
276
Barcelona, Salamanca
2024-12-04
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Barcelona, Huelva, Madrid, Pamplona, Santander, Seville
2024-12-04
Active, closed
Janssen Research & Development, LLC
Phase 1
19
Barcelona, L'Hospitalet de Llobregat, Madrid
2024-10-22
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Barcelona, Madrid, Pamplona, Seville, Valencia
2024-10-18
Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT06663319Colorectal Neoplasms, Gastrointestinal Neoplasms
DrugsFolfox·Bevacizumab
Janssen Research & Development, LLC
Phase 1
260
Barcelona, Madrid
2024-10-15
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Barcelona, Burjassot, Córdoba, Madrid, Majadahonda, Pamplona, Sant Cugat del Vallès, Seville
2024-09-19
Recruiting
Janssen Research & Development, LLC
Phase 2
210
Badalona, Barcelona, El Palmar, Jerez de la Frontera, Madrid, Pozuelo de Alarcón, Salamanca
2024-08-26
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Barcelona, Bilbao, Collado Villalba, Madrid, Torrevieja
2024-07-25
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2024-06-07
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Barcelona, Córdoba, Madrid, Santander, Santiago de Compostela
2024-05-30
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Barcelona, Madrid
2024-04-22
Recruiting
Janssen Research & Development, LLC
Phase 3
641
A Coruña, Alzira, Barcelona, Cadiz, Castellon, Jerez de la Frontera, Madrid, Málaga
2024-04-18
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Badalona, Barcelona, Madrid, Málaga, Sabadell, Santander, Seville, Valencia
2024-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Alcorcón, Badalona, Barcelona, Manises, Salamanca, Santiago de Compostela, Seville, Villajoyosa
2024-03-09
Active, closed
Janssen Research & Development, LLC
Phase 2
305
A Coruña, Alicante, Barcelona, Jaén, Lugo, Madrid, Málaga, Seville
2024-02-16
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Asturias, Barcelona, Burgos, Cáceres, Donostia / San Sebastian, Granada, Lugo, Madrid
2024-01-22
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Alicante, Barakaldo, Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Valencia
2024-01-17
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Barcelona, Madrid, Seville
2023-12-20
Recruiting
A Study of JNJ-87890387 for Advanced Solid Tumors
NCT06178614Neoplasms, Advanced Solid Tumors
Janssen Research & Development, LLC
Phase 1
200
Barcelona, Madrid
2023-12-14
Active, closed
Janssen Research & Development, LLC
Phase 1
70
Barcelona, Madrid, Pamplona, Salamanca
2023-12-06
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Alcorcón, Alicante, Barcelona, Bilbao, Madrid, Palma de Mallorca, Santiago de Compostela, Seville
2023-10-12
Active, closed
Janssen Research & Development, LLC
Phase 3
311
Badalona, Barcelona, Esplugues de Llobregat, Granada, Madrid, Manises, Seville, Valencia
2023-10-12
Active, closed
Janssen Research & Development, LLC
Phase 1/2
71
Alicante, Barcelona, Madrid, Seville, Valencia
2023-05-18
Active, closed
Janssen Research & Development, LLC
Phase 2
68
Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Málaga, Palma de Mallorca, Santiago de Compostela
2023-05-18
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05818683Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
DrugsJNJ-101556143·Lutetium Lu 177 vipivotide tetraxetan·Pasritamig·Cabazitaxel
Janssen Research & Development, LLC
Phase 1
300
Barcelona, Madrid
2023-04-26
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
A Coruña, Alicante, Barcelona, El Palmar, Lleida, Madrid, Manises, Málaga
2023-04-11
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
A Coruña, Algeciras, Barcelona, Cadiz, Castellon, L'Hospitalet de Llobregat, Lugo, Madrid
2023-03-23
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2023-02-15
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Alcorcón, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Pozuelo de Alarcón
2022-12-15
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
A Coruña, Alicante, Barcelona, Madrid, Seville, Valencia
2022-12-13
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
NCT05652335Relapsed or Refractory Multiple Myeloma, Previously Treated Amyloid Light-chain (AL) Amyloidosis
DrugRamantamig
Janssen Research & Development, LLC
Phase 1
180
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2022-11-22
Recruiting
Janssen Research & Development, LLC
Phase 2
520
A Coruña, Alicante, Barcelona, Madrid, Málaga, Seville, Valencia
2022-11-11
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Palma de Mallorca, Pozuelo de Alarcón, Salamanca
2022-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Badalona, Barcelona, El Palmar, Jerez de la Frontera, León, Madrid, Málaga, Pamplona
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 1
196
Barcelona, Madrid, Pamplona
2022-10-04
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Alicante, Barcelona, Bilbao, Donostia / San Sebastian, Madrid, Seville
2022-09-23
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Barcelona, Madrid, Pamplona, Pontevedra, Sabadell, Santander, Torrejón de Ardoz, Vigo
2022-09-19
Active, closed
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
NCT05421663Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse
Janssen Research & Development, LLC
Phase 1/2
166
Barcelona, Madrid
2022-08-12
Active, closed
Janssen Research & Development, LLC
Phase 3
418
A Coruña, Alicante, Barcelona, Córdoba, Las Palmas de Gran Canaria, Lugo, Madrid, Majadahonda
2022-08-05
Recruiting
Janssen Research & Development, LLC
Phase 1/2
225
Barcelona, Madrid, Santander, Valencia
2022-07-29
Active, closed
Janssen Research & Development, LLC
Phase 2
36
Barcelona, Madrid, Santander
2022-07-05
Active, closed
Janssen Research & Development, LLC
Phase 1/2
235
Barcelona, Córdoba, Madrid, Valencia
2022-04-11
Active, closed
Janssen Research & Development, LLC
Phase 2
151
Badalona, Barcelona, Madrid, Pamplona, Salamanca
2022-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
776
A Coruña, Barcelona, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Barcelona, Gijón, Las Palmas de Gran Canaria, Madrid, Palma, Pamplona, Pozuelo de Alarcón, Salamanca
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 4
411
A Coruña, Barakaldo, Barcelona, Bilbao, Córdoba, Madrid, Málaga, Sabadell
2021-08-30
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Salamanca, Santander, Seville
2021-08-19
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Alicante, Barcelona, Bilbao, Seville, Valencia
2021-07-15
Recruiting
Janssen Research & Development, LLC
Phase 1/2
420
Barcelona, Madrid, Pamplona, Salamanca, Seville, Valencia
2021-05-19
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Badalona, Barcelona, Madrid, Murcia, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2021-02-01
Active, closed
Janssen Research & Development, LLC
Phase 2
220
A Coruña, Badalona, Barcelona, Cadiz, Granada, Jerez de la Frontera, Madrid, Málaga
2020-12-18
Active, closed
Janssen Research & Development, LLC
Phase 1/2
228
Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca, Santander
2020-12-15
Active, closed
Janssen Research & Development, LLC
Phase 3
518
A Coruña, Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Sabadell, Santander
2020-12-07
Active, closed
Janssen Research & Development, LLC
Phase 3
308
A Coruña, Badalona, Barcelona, Burgos, Madrid, Majadahonda, Málaga, Pamplona
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
A Coruña, Badalona, Barcelona, Burgos, Girona, Madrid, Majadahonda, Málaga
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
A Coruña, Barcelona, Castellon, Girona, Jerez de la Frontera, Madrid, Málaga, Sabadell
2020-09-23
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Badalona, Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2020-09-17
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Seville
2020-06-12
Active, closed
Janssen Research & Development, LLC
Phase 1
290
Barcelona, Madrid, Pamplona, Salamanca
2020-02-21
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Badalona, Barcelona, Girona, Madrid, Santander, Seville
2019-09-26
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Barcelona, Madrid, Seville
2019-09-04
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Alcalá de Henares, Badalona, Barcelona, Burgos, Córdoba, Las Palmas de Gran Canaria, Madrid, Majadahonda
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
A Coruña, Barcelona, Cadiz, Castellon, Jerez de la Frontera, Madrid, Manacor, Málaga
2019-06-11
Active, closed
Janssen Research & Development, LLC
Phase 3
765
A Coruña, Barcelona, Jerez de la Frontera, Madrid, Málaga, Pozuelo de Alarcón, Sabadell, Santander
2019-01-25
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Barakaldo, Barcelona, Madrid, Málaga, Seville
2018-10-29
Active, closed
Janssen Research & Development, LLC
Phase 3
211
Barcelona, Madrid, Pamplona, Salamanca, Seville
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Barcelona, Madrid, Málaga, Ourense, Pontevedra, Pozuelo de Alarcón, Sabadell, Santander
2018-04-05
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Badajoz, Badalona, Barcelona, Cáceres, Córdoba, Granada, Jaén, Las Palmas de Gran Canaria
2018-03-23
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Barcelona, Madrid, Málaga
2018-03-02
Active, closed
Janssen Research & Development, LLC
Phase 1
302
Badalona, Barcelona, Pamplona, Salamanca
2017-05-16
Active, closed
Janssen Research & Development, LLC
Phase 1/2
234
Badalona, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2016-11-21
Active, closed
Janssen Research & Development, LLC
Phase 1
751
A Coruña, Barcelona, Madrid, Málaga, Santander, Seville
2016-05-24
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Badalona, Barcelona, Madrid, Málaga, Pamplona, Sabadell, Santander, Santiago de Compostela
2015-04-22
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Salamanca
2013-09-09
Rows per page Showing 1–96 of 96
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/barcelona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 96 of those studies with a site in Barcelona that also match the filters currently applied.

How many clinical trials are recruiting in Barcelona?

36 of the 96 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 59 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Barcelona), 96 studies
PhaseStudiesRecruitingShare
Phase 3461747.9%
Phase 118718.8%
Phase 215515.6%
Phase 1/210310.4%
Phase 2/3535.2%
Observational111%
Phase 4101%

Most active sponsors

Lead sponsors with the most studies (Barcelona)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC9636
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.